|
|
Volumn 19, Issue 8, 2010, Pages 1002-1005
|
|
Drug development costs when financial risk is measured using the Fama-French three-factor model
a,b
a
IL
(United States)
|
|
Author keywords
Cost of capital; Cost of drug development; Drug development; Fama French three factor model
|
|
Indexed keywords
ARTICLE;
CAPITAL;
COST BENEFIT ANALYSIS;
DRUG APPROVAL;
DRUG COST;
DRUG DEVELOPMENT;
DRUG MARKETING;
FAMA FRENCH THREE FACTOR MODEL;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
MATHEMATICAL MODEL;
PRIORITY JOURNAL;
PROSPECTIVE PRICING;
TAX;
COST;
DRUG INDUSTRY;
DRUG SCREENING;
ECONOMICS;
HUMAN;
PROCEDURES;
RISK;
STATISTICAL MODEL;
STATISTICS AND NUMERICAL DATA;
UNITED STATES;
CAPITAL FINANCING;
COSTS AND COST ANALYSIS;
DRUG APPROVAL;
DRUG DISCOVERY;
DRUG EVALUATION;
DRUG INDUSTRY;
HUMANS;
MODELS, ECONOMETRIC;
RISK;
UNITED STATES;
|
|
EID: 77955045274
PISSN: 10579230
EISSN: 10991050
Source Type: Journal
DOI: 10.1002/hec.1538 Document Type: Article |
|
Times cited : (77)
|
|
References (6)
|
